Novartis Silences Generic Fears With Blowout Quarter, Packed Pipeline

Novartis AG (NYSE:NVS) reported better-than-expected second-quarter earnings on Tuesday as strong demand for its priority medicines offset the impact …
Read from Source · benzinga.com ↗
This content is automatically aggregated. Full credit goes to the original publisher (benzinga.com).


